Lung function and postural changes during pregnancy.

Aarhus University Hospital, Aarhus, Central Jutland, Denmark
Respiratory Medicine (Impact Factor: 2.92). 12/1989; 83(6):467-70. DOI: 10.1016/S0954-6111(89)80127-1
Source: PubMed

ABSTRACT The aim of this study was to determine the effects of postural changes on lung function in pregnant women during the first, second, third trimester and post partum. A significant decrease in FRC, PEF and FEV1 was observed as a result of the postural changes. Arterial oxygenation, MVV and DLCO remained largely the same.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Pre-eclampsia remains an enigma despite extensive research. It is a common obstetric disorder and has multi-system ramifications. Previous research has concluded that the parameters of forced spirometry remain unchanged in normal pregnancy compared with non-pregnant controls. This study revealed that pre-eclampsia significantly alters lung function and implies that non-pregnant spirometric normograms may not reliably reflect concomitant pulmonary disease in such women.
    Journal of Obstetrics and Gynaecology 11/2007; 27(7):672-5. DOI:10.1080/01443610701667791 · 0.60 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sarcoidosis is a multisystemic disease of unknown etiology, characterized by granulomatous inflammation. It typically presents between the ages of 20 to 40 years old. An estimated 0.02% to 0.05% of pregnancies occur in patients with sarcoidosis. Although fetal loss has been reported in mothers with sarcoidosis, limited studies do not suggest an in-crease risk of fetal or neonatal complications. Several reports suggest an improvement of sarcoidosis during pregnancy. Sarcoidosis, a Th1-mediated disease, seems to follow the same course as rheumatoid arthritis during pregnancy and post-partum. Estrogen levels increase during pregnancy, resulting in a decreased Th1-mediated immune response, which can improve active sarcoidosis. Free plasma cortisol concentrations increase in pregnancy, with plasma levels 2-to 3-fold higher than those of non-pregnant controls, suggesting greater tissue exposure to glucocorticoids during pregnancy. This may result in decreased granulomatous inflammation with improvement in symptoms and clinical findings. During the postpartum period, when free cortisol levels return to the prior non-pregnant levels, reactivation of sarcoidosis can occur. The majority of patients with sarcoidosis will either have a stable disease or will experience improvement in their symp-toms. A small group of pregnant mother with active sarcoidosis, however, may develop more progressive disease during pregnancy. The manifestations, course of disease, and treatment options during pregnancy and postpartum period are dis-cussed. Sarcoidosis is a multisystemic disease of unknown etiol-ogy, characterized by granulomatous inflammation. It typi-cally presents between the ages of 20 to 40 years old. An estimated 0.02% to 0.05% of pregnancies occur in patients with sarcoidosis [1, 2]. Lungs, mediastinal lymph nodes, skin, liver, central nervous system, heart, and eyes are com-monly involved. Sarcoidosis usually has a benign course, but severe organ injury resulting in death can occur. In an obser-vational study over 14 years, Freid reported mortality rate of 1.4% in 205 women with sarcoidosis [3]. One of the earliest reports of sarcoidosis in pregnancy was by Nordland et al. in 1946. He reported a case of throm-bocytopenia purpura in a 26 year-old pregnant woman. Sple-nectomy was performed in the second trimester of pregnancy with pathology of spleen being consistent with sarcoidosis [4]. The first cases of intrathoracic sarcoidosis were de-scribed by Aykan et al. in 1950. One patient gave birth to a stillborn, and the other to healthy infant. The authors con-cluded that pregnancy and sarcoidosis may coexist without affecting each other [5]. Berman in 1951 reported a patient with sarcoidosis who had two normal full-term pregnancies. Improvement in sarcoidosis was noted during the second pregnancy [6].
    Current Respiratory Medicine Reviews 02/2007; 3(1). DOI:10.2174/157339807779941749
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Symptoms of sleep-disordered breathing are more common in pregnant women compared with nonpregnant women. It is likely that physiology of pregnancy predisposes to the development or worsening of sleep-disordered breathing, but some physiologic changes may also be protective against the development of this disease. Clinical presentation may be less predictive of sleep disordered breathing in pregnancy than in the non-pregnant population; nonetheless, snoring is associated with adverse pregnancy outcomes. Treatment strategies are similar to the nonpregnant population, however, pregnancy-specific scenarios may arise and these subtleties are addressed in this review.
    Clinics in chest medicine 03/2011; 32(1):175-89, x. DOI:10.1016/j.ccm.2010.11.003 · 2.17 Impact Factor